Find supporting resources for our platform.
- Application Note
- Primary Literature
eProtein Discovery™: An overview
Get to know more about this platform which gives you soluble, active proteins in 48 hours for your downstream applications.
Nuclera helps accelerate understanding of COVID-19
Nuclera collaborates with the University of Southampton to understand COVID-19.
Application Note: Rapid cell-free expression and solubility screening to obtain active human VEGF with eProtein Discovery™ platform
VEGF is a key regulator of angiogenesis and plays a central role in the process of tumor growth, making it an appealing target for anticancer therapeutics. This platform demonstrates time-saving for both soluble construct identification and micrograms of active proteins obtained in 48 hours.